← stocks-llm Find companies like SIBN →

SI BONE INC (SIBN)

Health Care · Orthopedic implants and devices · NASDAQ

SI-BONE develops minimally invasive implant systems for treating sacroiliac joint dysfunction, a common source of lower back and leg pain.

What SI BONE INC does

SI-BONE designs, manufactures, and commercializes implantable devices and surgical instruments for sacroiliac joint fusion procedures. The company's portfolio addresses disorders of the spinopelvic anatomy, with the sacroiliac joint being a primary focus. SI-BONE markets its products to orthopedic surgeons and neurosurgeons, working to establish physician adoption and secure reimbursement from third-party payors. The company is pursuing clinical development and regulatory approvals across multiple jurisdictions including the FDA and European regulatory bodies.

Themes: ["Spine and pelvis","Minimally invasive surgery","Orthopedic devices"]

Fundamentals

Ask why SIBN looks like this →

Key risks (from latest filing)

["Intense competition from larger medical device companies with greater resources (Medtronic, Globus Medical, Alphatec), which may develop superior or patented competing products faster than SI-BONE can commercialize","Significant accumulated operating losses ($450.3 million as of end-2025) and continued unprofitability; reliance on capital market access to fund operations","Dependence on a limited number of suppliers and sole-source suppliers for instruments and materials; tariff impacts and supply chain disruptions could affect product availability and gross margins"]

See SIBN's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.